PES14 RESPONSIVENESS OF SELF-REPORTED VISUAL FUNCTIONING IN AGE-RELATED MACULAR DEGENERATION (AMD) PATIENTS TO GENERAL HEALTH AND CHANGES IN VISUAL ACUITY IN A PHASE I/II RANDOMIZED CONTROLLED TRIAL OF LUCENTISTM (RANIBIZUMAB; RHUFAB V2)
Abstract
Authors
D Globe IQ Tonnu TS Chang J Fine